EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The pharmacological treatment of epilepsy in adults

Torbjörn Tomson iD, Johan Zelano iD, Yew Li Dang iD, Piero Perucca iD

Epileptic Disorders · 2023-10 · 25 (5) · 649-669

DOI: 10.1002/epd2.20093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epileptic Disorders, online erschienen am 08.07.2023. Verfasst von Torbjörn Tomson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmacological treatment of epilepsy entails several critical decisions that need to be based on an individual careful risk–benefit analysis. These include when to initiate treatment and with which antiseizure medication (ASM). With more than 25 ASMs on the market, physicians have opportunities to tailor the treatment to individual patients´ needs. ASM selection is primarily based on the patient's type of epilepsy and spectrum of ASM efficacy, but several other factors must be considered. These include age, sex, comorbidities, and concomitant medications to mention the most important. Individual susceptibility to adverse drug effects, ease of use, costs, and personal preferences should also be taken into account. Once an ASM has been selected, the next step is to decide on an individual target maintenance dose and a titration scheme to reach this dose. When the clinical circumstances permit, a slow titration is generally preferred since it is associated with improved tolerability. The maintenance dose is adjusted based on the clinical response aiming at the lowest effective dose. Therapeutic drug monitoring can be of value in efforts to establish the optimal dose. If the first monotherapy fails to control seizures without significant adverse effects, the next step will be to gradually switch to an alternative monotherapy, or sometimes to add another ASM. If an add‐on is considered, combining ASMs with different modes of action is usually recommended. Misdiagnosis of epilepsy, non‐adherence and suboptimal dosing are frequent causes of treatment failure and should be excluded before a patient is regarded as drug‐resistant. Other treatment modalities, including epilepsy surgery, neuromodulation, and dietary therapies, should be considered for truly drug‐resistant patients. After some years of seizure freedom, the question of ASM withdrawal often arises. Although successful in many, withdrawal is also associated with risks and the decision needs to be based on careful risk–benefit analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyHumansAdult

Stichwörter der Autor:innen

antiseizure medicationepilepsypharmacotherapy

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
  • Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Wallenberg Center of Molecular and Translational Medicine, Gothenburg University, Gothenburg, Sweden.
  • Bladin-Berkovic Comprehensive Epilepsy Program, Austin Health, Melbourne, Victoria, Australia.
  • Epilepsy Research Centre, Department of Medicine (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Torbjörn Tomson, Johan Zelano, Yew Li Dang, Piero Perucca

Zitieren

APA

Tomson, T., Zelano, J., Dang, Y. L., & Perucca, P. (2023). The pharmacological treatment of epilepsy in adults. Epileptic Disorders, 25(5), 649-669. https://doi.org/10.1002/epd2.20093

Vancouver

Tomson T, Zelano J, Dang YL, Perucca P. The pharmacological treatment of epilepsy in adults. Epileptic Disorders. 2023;25(5):649-669. doi:10.1002/epd2.20093

BibTeX
@article{Tomson2023,
  author = {Tomson, Torbjörn and Zelano, Johan and Dang, Yew Li and Perucca, Piero},
  title = {The pharmacological treatment of epilepsy in adults},
  journal = {Epileptic Disorders},
  year = {2023},
  volume = {25},
  number = {5},
  pages = {649--669},
  doi = {10.1002/epd2.20093}
}
Kostenlos starten →